News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Roche (JOBS) Seen Upping $42 Billion Genentech, Inc. (JOBS) Bid After Rebuff
February 24, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ZURICH, Feb 24 (Reuters) - Roche will likely have to up its bid for the 44 percent of Genentech it does not own, analysts said on Tuesday, after the U.S. biotech group urged shareholders to reject the offer.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
Genentech, Inc.
Roche
MORE ON THIS TOPIC
Mergers & acquisitions
Another Bidding War Breaks as Lundbeck Bids for Sleep Biotech Avadel
November 14, 2025
·
1 min read
·
Annalee Armstrong
Mergers & acquisitions
Merck Again Brings Out Big Bucks, Buys Cidara in $9.2B Antiviral Push
November 14, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Pfizer Closes Metsera Deal, Officially Ending Bidding War Drama
November 13, 2025
·
1 min read
·
Annalee Armstrong
China
Recently Launched Third Arc Turns to China for Cancer T Cell Engagers
November 13, 2025
·
2 min read
·
Tristan Manalac